Cargando…

[(68)Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model – comparison with [(18)F]FDG PET/CT, MRI and ex vivo receptor expression

PURPOSE: The aim was to characterize the properties of [(68)Ga]Pentixafor as tracer for prostate cancer imaging in a PC-3 prostate cancer xenograft mouse model and to investigate its correlation with [(18)F]FDG PET/CT, magnetic resonance imaging (MRI) and ex vivo analyses. METHODS: Static [(68)Ga]Pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarzenböck, Sarah M., Stenzel, Jan, Otto, Thomas, Helldorff, Heike V., Bergner, Carina, Kurth, Jens, Polei, Stefan, Lindner, Tobias, Rauer, Romina, Hohn, Alexander, Hakenberg, Oliver W., Wester, Hans J., Vollmar, Brigitte, Krause, Bernd J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707047/ https://www.ncbi.nlm.nih.gov/pubmed/29221153 http://dx.doi.org/10.18632/oncotarget.21024

Ejemplares similares

Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [(68)Ga]pentixafor
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

[(68)Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
por: Breun, Maria, et al.
Publicado: (2019)

Targeting CXCR4 with [(68)Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
por: Lapa, Constantin, et al.
Publicado: (2017)

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients
por: Lewis, Richard, et al.
Publicado: (2021)

CXCR4 PET imaging of mantle cell lymphoma using [(68)Ga]Pentixafor: comparison with [(18)F]FDG-PET
por: Mayerhoefer, Marius E., et al.
Publicado: (2021)

Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [(68)Ga]Ga-Pentixafor-PET/MRI
por: Haug, Alexander R., et al.
Publicado: (2019)

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
por: Benčurová, Katarína, et al.
Publicado: (2022)

Current Status of (68)Ga-Pentixafor in Solid Tumours
por: Hadebe, Bawinile, et al.
Publicado: (2022)

[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [(18)F]FDG and laboratory values
por: Lapa, Constantin, et al.
Publicado: (2017)

Response assessment with the CXCR4-directed positron emission tomography tracer [(68)Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities
por: Herhaus, Peter, et al.
Publicado: (2017)

Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [(68)Ga] Pentixafor Internalization in Neuroendocrine Tumor Cells
por: Weich, Alexander, et al.
Publicado: (2021)

Synthesis, validation and quality controls of [(68)Ga]-DOTA-Pentixafor for PET imaging of chemokine receptor CXCR4 expression
por: Sammartano, Antonino, et al.
Publicado: (2020)

Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [(68)Ga]pentixafor PET/CT
por: Derlin, Thorsten, et al.
Publicado: (2018)

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
por: Lapa, Constantin, et al.
Publicado: (2016)

Application of in vivo imaging techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer
por: Rohde, Sarah, et al.
Publicado: (2017)

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
por: Osl, Theresa, et al.
Publicado: (2020)

[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
por: Li, Xiang, et al.
Publicado: (2017)

First (18)F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather
por: Jacobs, Sarah M., et al.
Publicado: (2021)

Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [(68)Ga]Ga-PentixaFor PET/CT
por: Serfling, Sebastian E., et al.
Publicado: (2022)

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [(68)Ga]PentixaFor PET/MRI—Compared with [(18)F]FDG PET/MRI
por: Lu, Xia, et al.
Publicado: (2022)

[(68)Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery
por: Li, Xiang, et al.
Publicado: (2019)

Automated synthesis and quality control of [(68)Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging
por: Daniel, Thomas, et al.
Publicado: (2023)

[(18)F]fallypride-PET/CT Analysis of the Dopamine D(2)/D(3) Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection
por: Mann, Teresa, et al.
Publicado: (2018)

[(68)Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with (18)F[FDG] PET Imaging
por: Lawal, Ismaheel O., et al.
Publicado: (2020)

[(68)Ga]-NODAGA-RGD Positron Emission Tomography (PET) for Assessment of Post Myocardial Infarction Angiogenesis as a Predictor for Left Ventricular Remodeling in Mice after Cardiac Stem Cell Therapy
por: Lang, Cajetan Immanuel, et al.
Publicado: (2020)

Automated Radiosynthesis, Quality Control, and Biodistribution of Ga-68 Pentixafor: First Indian Experience
por: Watts, Ankit, et al.
Publicado: (2021)

[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
por: Lapa, Constantin, et al.
Publicado: (2016)

Anatomical MRI and [(18)F]FDG PET/CT imaging of Schistosoma mansoni in a NMRI mouse model
por: Lindner, Tobias, et al.
Publicado: (2020)

Fully-automated production of [(68)Ga]Ga-PentixaFor on the module Modular Lab-PharmTracer
por: Spreckelmeyer, Sarah, et al.
Publicado: (2020)

Accuracy of PET quantification in [(68)Ga]Ga-pentixafor PET/MR imaging of carotid plaques
por: Rausch, Ivo, et al.
Publicado: (2020)

Imaging findings and clinical relevance of (68)Ga-Pentixafor PET in atherosclerosis: a systematic review
por: Wang, Min, et al.
Publicado: (2023)

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

(68)Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease
por: Pan, Qingqing, et al.
Publicado: (2023)

Accuracy of Gallium-68 Pentixafor Positron Emission Tomography–Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism
por: Hu, Jinbo, et al.
Publicado: (2023)

A dataset of [(68)Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma
por: Roustaei, Hessamoddin, et al.
Publicado: (2023)

Reduced splenic uptake on (68)Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
por: Kraus, Sabrina, et al.
Publicado: (2022)

Streamlined Schemes for Dosimetry of (177)Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
por: Kurth, Jens, et al.
Publicado: (2021)

One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet
por: Schmidt, Anke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qgjpme95fsgvfa3r2kig5nopu2